Military | Bexson Biomedical

Ease of Use:
Stick it, Activate, Move on

Connectivity & Data Exchange: Logistical Advantage

Potential for Additional Medications and Features

Administer in Seconds. Potentially >25x Faster Deployment

Eliminates IV Delivery Errors in “fog of war”

Greatly Enhanced Mobility

Less than 150g
> 10x Lighter

Agile Combat Deployment

Smaller
Size

Less
Weight

Faster Administration

Three major factors for replacing IV administration with AKESO™.

Bexson's dual technologies (novel formulation and wearable delivery) reduce complexity and the need for heavy saline while also improving delivery timeframes and therapy options.

AKESO has the potential to replace battlefield IV delivery and can decrease the 15+ complex steps fraught with potential error-points with an innovative “stick it, activate and move on” subcutaneous administration

Our solutions decrease weight, initiate pain therapy more rapidly, and provide drug delivery for Prolonged Field Care that is faster, lighter, and requires minimal training.

BENEFITS

Current IV stats vs. AKESO Wearable Device

Bexson’s SEVALENT formulation technology will revolutionize field based pain treatment. AKESO can provide extended therapy to military personnel via continuous delivery over multiple days.
Programmed delivery frees time for medic/corpsman.

Significant saline + drug API is required vs. AKESO prefilled & preloaded from manufacturer

Manual and complex venous insertion by medic vs. user-applied

Greater than 1kg vs. less than 150 grams

>5 minute application vs. less than a minute

15+ individual steps vs. "stick it, activate, move on"

Additional Therapeutic Options via Military Partnerships

Transitioning IV delivery to a wearable device is possible because of Bexson's patented SEVALENT^TM chemistry platform.

BB106 – Ketamine

Ketamine API via IV is a TCCC current solution

BB605 – Naloxone

Steady-state delivery
innovation protects against weaponized aerosol opioids

BB90X – TXA Tranexamic Acid

Hemorrhage
Currently IV delivered

Antibiotics

Prevent infection

Future Innovation Potential Generation 2:
Connect to Patient Tracking and Logistics integration

Battlefield Monitoring and Communication

Contested environments will require mobile tools for battlefield patient care.

AKESO has the potential to transmit data and greatly improve warfighter monitoring throughout the continuum of care.

Introducing AKESO:
On-Body Delivery System for Drug Delivery in Contested Environments

Ease of Use:
Stick it, Activate, Move on

Connectivity & Data Exchange: Logistical Advantage

Potential for Additional Medications and Features

Administer in Seconds. Potentially >25x Faster Deployment

Eliminates IV Delivery Errors in “fog of war”

Greatly Enhanced Mobility

Less than 150g
> 10x Lighter

Agile Combat Deployment

Three major factors for replacing IV administration with AKESO™.

Current IV stats vs. AKESO Wearable Device

Downloadable Military Media

Additional Therapeutic Options via Military Partnerships

BB106 – Ketamine

BB605 – Naloxone

BB90X – TXA Tranexamic Acid

Antibiotics

Battlefield Monitoring and Communication

Signup for Updates

Ease of Use:Stick it, Activate, Move on

Connectivity & Data Exchange: Logistical Advantage

Potential for Additional Medications and Features

Administer in Seconds. Potentially >25x Faster Deployment

Eliminates IV Delivery Errors in “fog of war”​

Greatly Enhanced Mobility​

Less than 150g> 10x Lighter

Agile Combat Deployment​

Three major factors for replacing IV administration with AKESO™.

Current IV stats vs. AKESO Wearable Device​

Downloadable Military Media

Additional Therapeutic Options via Military Partnerships

BB106 – Ketamine​

BB605 – Naloxone

BB90X – TXA Tranexamic Acid

Antibiotics

Battlefield Monitoring and Communication

Ease of Use:
Stick it, Activate, Move on

Eliminates IV Delivery Errors in “fog of war”

Greatly Enhanced Mobility

Less than 150g
> 10x Lighter

Agile Combat Deployment

Current IV stats vs. AKESO Wearable Device

BB106 – Ketamine